Cargando…

Changes in levels of angiotensin II and its receptors in a model of inverted stress-induced cardiomyopathy

BACKGROUND: Stress-induced cardiomyopathy (SIC) has gained increasing attention worldwide and is characterized by extensive ventricular akinesis, Beta-blockers and angiotensin-converting enzyme inhibitors (ACEIs) are the main treatments for SIC patients. The pharmacological mechanism of action of be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xi, Yin-yan, Liu, Bei, Yang, Li-xia, Kuang, Chen-wei, Guo, Rui-wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240840/ https://www.ncbi.nlm.nih.gov/pubmed/25297539 http://dx.doi.org/10.1186/s40001-014-0054-8

Ejemplares similares

A Rare Case of Iatrogenic Inverted Stress Cardiomyopathy
por: Lotfian, Parviz-Ali, et al.
Publicado: (2022)

Pheochromocytoma as a Rare Hidden Cause of Inverted Stress Cardiomyopathy
por: Cho, Soo Kyung, et al.
Publicado: (2014)

Inverted Takotsubo Cardiomyopathy Induced by Dobutamine Stress Echocardiography with Atypical Presentation
por: Cadeddu, Christian, et al.
Publicado: (2011)

Inverted stress cardiomyopathy during monitored anesthesia care for endoscopic sinus surgery
por: Koo, Min Seok, et al.
Publicado: (2013)

Mechanical Stress Triggers Cardiomyocyte Autophagy through Angiotensin II Type 1 Receptor-Mediated p38MAP Kinase Independently of Angiotensin II
por: Lin, Li, et al.
Publicado: (2014)

Changes of plasma aldosterone and angiotensin II levels in patients with ischemic cardiomyopathy combined with Type-2 diabetes mellitus and their clinical significance
por: Tang, Renmin, et al.
Publicado: (2022)

The use of angiotensin II receptor blocker is associated with greater recovery of cardiac function than angiotensin‐converting enzyme inhibitor in dilated cardiomyopathy
por: Enzan, Nobuyuki, et al.
Publicado: (2022)

Nlrp3 Deficiency Alleviates Angiotensin II-Induced Cardiomyopathy by Inhibiting Mitochondrial Dysfunction
por: Chen, Yu, et al.
Publicado: (2021)

PKN2 deficiency leads both to prenatal ‘congenital’ cardiomyopathy and defective angiotensin II stress responses
por: Marshall, Jacqueline J.T., et al.
Publicado: (2022)

Inverted-Takotsubo Cardiomyopathy in a Patient with Pulmonary Embolism
por: Lee, Seung-Hyun, et al.
Publicado: (2013)

Inverted (Reverse) Takotsubo Cardiomyopathy following Cerebellar Hemorrhage
por: Piérard, Sophie, et al.
Publicado: (2014)

Acute Appendicitis as an Unexpected Cause of Inverted Takotsubo Cardiomyopathy
por: Mihalcea-Danciu, Mihaela, et al.
Publicado: (2018)

One amino acid change of Angiotensin II diminishes its effects on abdominal aortic aneurysm
por: Wang, Ya, et al.
Publicado: (2019)

Angiotensin II Mediates Cardiomyocyte Hypertrophy in Atrial Cardiomyopathy via Epigenetic Transcriptional Regulation
por: Zheng, Liuying, et al.
Publicado: (2022)

Advances in the allostery of angiotensin II type 1 receptor
por: Zhang, Xi, et al.
Publicado: (2023)

Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference
por: Safari, Tahereh, et al.
Publicado: (2013)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Inverted Takotsubo cardiomyopathy: A rare entity often missed!
por: Banerjee, Suvro
Publicado: (2016)

Inverted Takotsubo Cardiomyopathy as an Early Complication After Liver Transplantation
por: Bedanova, Helena, et al.
Publicado: (2021)

Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes
por: Wang, Shuya, et al.
Publicado: (2016)

Angiopoietin-like protein 2 expression is suppressed by angiotensin II via the angiotensin II type 1 receptor in rat cardiomyocytes
por: Wang, Shuya, et al.
Publicado: (2020)

Angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers and hemorrhoids: A nationwide, population-based study
por: Hu, Wei-Syun, et al.
Publicado: (2023)

Effect of Angiotensin II on Chondrocyte Degeneration and Protection via Differential Usage of Angiotensin II Receptors
por: Nishida, Takashi, et al.
Publicado: (2021)

SAT-562 Angiotensin II Induces Aldosterone Synthesis in the Rat Heart Stressed by Angiotensin II
por: Bose, Himangshu S, et al.
Publicado: (2020)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021)

The appropriate dose of angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?
por: Ishida, Junichi, et al.
Publicado: (2015)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Tu, Bin, et al.
Publicado: (2021)

Prediction of left ventricular reverse remodeling after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy
por: Matsumura, Yoshihisa, et al.
Publicado: (2015)

Inverted Takotsubo cardiomyopathy after attempted suicidal hanging – Two cases
por: Sengupta, Shantanu, et al.
Publicado: (2016)

Inverted Takotsubo Cardiomyopathy Associated With the Consumption of a Weight Management Supplement
por: Dai, Zhehao, et al.
Publicado: (2019)

Pheochromocytoma-induced “inverted” takotsubo cardiomyopathy and cardiogenic shock: case report
por: Odierna, Italia, et al.
Publicado: (2022)

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
por: Vasile, Silvana, et al.
Publicado: (2020)

Structural Basis for Selectivity and Diversity in Angiotensin II Receptors
por: Zhang, Haitao, et al.
Publicado: (2017)

Angiotensin II Type 1 Receptor-associated Protein Inhibits Angiotensin II-induced Insulin Resistance with Suppression of Oxidative Stress in Skeletal Muscle Tissue
por: Ohki, Kohji, et al.
Publicado: (2018)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Eprosartan mesylate, an angiotensin II receptor antagonist
por: Qian, Jing-Jing, et al.
Publicado: (2011)

Pharmacologic Activation of Angiotensin-Converting Enzyme II Alleviates Diabetic Cardiomyopathy in db/db Mice by Reducing Reactive Oxidative Stress
por: Kim, Donghyun, et al.
Publicado: (2023)

Circulating angiotensin II deteriorates left ventricular function with sympathoexcitation via brain angiotensin II receptor
por: Shinohara, Keisuke, et al.
Publicado: (2015)

Angiotensin-Converting Enzyme Inhibitor-Induced Oropharyngeal edema with Subsequent Stress-Cardiomyopathy
por: Cronin, Michael, et al.
Publicado: (2021)

Angiotensin 1-7 Protects against Angiotensin II-Induced Endoplasmic Reticulum Stress and Endothelial Dysfunction via Mas Receptor
por: Murugan, Dharmani, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ftbq2qgbntplsavkkkvjmfre7q